Pulmonary artery pressure matters – how to efficiently improve survival in pulmonary arterial hypertension (RCD code: II‐1A.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2017, Vol 3, Issue 4
Abstract
Pulmonary arterial hypertension is a disease characterized by poor prognosis despite treatment. Even in a modern era of pharmaco- therapy there is a strong need to further improve survival of patients. The current therapeutic strategies do not offer a real break-through in terms of reducing mortality. In a search for better efficacy of treatment we discuss a strategy based on lowering pulmonary artery pressure as much as possible with epoprostenol in monotherapy or in combination. Epoprostenol with bosentan is an effective tool in achieving this goal. A rapid up-titration regardless of maximum epoprostenol dose achieved gives additional long-term benefit. Practical issues related to such modality of treatment are also discussed. JRCD 2017; 3 (4): 110–115
Authors and Affiliations
Hiromi Matsubara, Piotr Błaszczak, Grzegorz Kopeć
Keywords
Related Articles
- EP ID EP245512
- DOI 10.20418/jrcd.vol3no4.295
- Views 107
- Downloads 0
Isolated left ventricular noncompaction in an asymptomatic althlete (RCD code: III-5A.1.0)
Left ventricular noncompaction (LVNC) is a rare form of cardiomyopathy due to abnormal morphogenesis of the endocardium and myocardium that occurs in early stages of foetal life. Given the increased risk of sudden cardia...
2nd International Conference on Rare Cardiovascular Diseases (Krakow, October 16–17, 2014)
The 2nd International Conference on Rare Cardiovascular Diseases was organized by the Krakow CRCD between 16th and 17th October 2014 at the John Paul II Hospital premises. The two-days Conference’s program was diverse, e...
Cardiac sarcoidosis – management and prognosis (RCD code: III‑3A.3)
Sarcoidosis is a systemic, granulomatous disease of unknown etiology. Cardiac involvement in the course of sarcoidosis occurs in 5% of patients. However, about 25% of patient with systemic/pulmonary sarcoidosis might pre...
Spontaneous coronary artery dissection secondary to intimal fibromuscular dysplasia (RCD code: I‑1C.O)
Fibromuscular dysplasia (FMD) is a nonatherosclerotic, noninflammatory arterial disease of unknown etiology. Histologically, FMD is classified on the basis of arterial layer involved into intimal, medial and perimedial...
Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death
We present the case of a young patient with significant left ventricular hypertrophy as a common representation of the hypertrophic cardiomyopathy (HCM) phenotype. The clinical presentation and diagnostic route of the di...